Neuro-Ophthalmology Care

For patients with vision or eye disorders caused by tumors, including orbital, optic nerve, pituitary or other intracranial lesions that compress the visual pathways, the team collaborates closely with regional experts in Ocular Oncology. This Program is fully integrated with Montefiore Einstein Comprehensive Cancer Center, among the elite 1% of National Cancer Institute (NCI)-designated comprehensive cancer centers in the U.S. For patients with inherited optic neuropathies, the team provides genetic counseling in collaboration with the Division of Pediatric Genetic Medicine, one of the nation’s first and best-known programs. This Division has been leading genetic and genomic disease care for over fifty years and continues to serve as a model for the field. The Department also provides access to comprehensive vision rehabilitation through close collaboration with Winifred Masterson Burke Rehabilitation Hospital, ranked among the top 1% of all hospitals in the nation for rehabilitation according to U.S. News & World Report.

The team at Montefiore Einstein Ophthalmology and Visual Sciences works closely with our Multiple Sclerosis and Neuroimmunology Center, an internationally recognized leader and the world’s first integrated clinical care and research program for multiple sclerosis (MS). Our specialists provide expert management of the full spectrum of ophthalmic conditions in patients with all types of MS and related syndromes, as well as other neuroimmunological disorders, including neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD).

Montefiore Einstein Ophthalmology and Visual Sciences is leading collaborative research and spearheading numerous studies and clinical trials, including several funded by the National Eye Institute/National Institutes of Health (NEI/NIH), translating novel scientific discoveries into new diagnostics and treatments to improve clinical outcomes for patients affected by, or at risk for, neuro-ophthalmic conditions. Through these clinical trials, patients can access emerging technologies and innovative treatments that may otherwise be unavailable to the general public.

Our research spans basic, translational and clinical science, with a focus on advancing the understanding of the mechanisms, diagnosis and treatment of neuro-ophthalmic conditions. Core areas of investigation include inflammatory and demyelinating optic neuropathies such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD); ischemic and vascular disorders, including idiopathic intracranial hypertension, and tumor- and treatment-related outcomes of the orbit, optic nerve and brain. Specialists are also exploring novel therapeutic strategies and leading-edge approaches, such as gene therapy, optogenetics, neuroprotective agents, AI-enhanced imaging and innovative surgical techniques to improve visual outcomes. 

Our team is pioneering the use of advanced machine learning techniques to identify quantifiable patterns of visual field loss and track treatment response in optic neuritis and idiopathic intracranial hypertension. In radiation and oncologic care, our researchers are also helping to define dose tolerances for the optic pathways in stereotactic radiosurgery, advancing safety and efficacy for patients requiring tumor-directed therapies. 

In addition to pioneering laboratory and clinical research, our faculty play a leading role on national and international panels that shape clinical practice. Our experts are members of the Preferred Practice Patterns Committee (PPPC), contributing to the development of the American Academy of Ophthalmology’s Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern® (PPP) guidelines, which help to identify and define characteristics and components of quality eye care and establish the standard of care for certain neuro-ophthalmic conditions. Our radiologists have also served on the multidisciplinary expert panel that developed the American College of Radiology (ACR) Appropriateness Criteria® for orbits, vision and visual loss, further reinforcing our leadership in defining standards of care worldwide.

We are one of only 13 centers worldwide designated as a Cochrane Eyes and Vision (CEV) Center for Evidence-Based Vision Care, an NEI/NIH-funded distinction recognizing our commitment to advancing evidence-based medicine and eye care. Our contributions to research and identifying the most effective treatments in patient care serve as a model for clinical sites around the world.

Whether you are newly diagnosed with a neuro-ophthalmic condition, experiencing double vision, involuntary eye movements (nystagmus) or vision loss, managing a long-term neurological disorder that affects vision or seeking a second opinion, our world-renowned team at Montefiore Einstein Ophthalmology and Visual Sciences is here to provide you with exceptional care, support and resources tailored to your individual needs.

Our full-service Center offers a comprehensive range of traditional and holistic care at every stage of life, from screening, prevention and diagnosis through treatment and recovery, including social and support services, genetic counseling for individuals with, or at risk for, inherited or complex eye conditions, patient education, care navigation, mental health and wellness services, vision rehabilitation and other supportive programs. Our breadth of resources enables us to deliver highly specialized, coordinated care that takes into account the whole person, addressing each individual’s medical needs to preserve, restore and enhance vision, prevent vision loss and improve outcomes and quality of life. Our team of compassionate and deeply knowledgeable doctors, nurses, specialists and support staff is dedicated to helping you at every step of your neuro-ophthalmic care journey.

Neuro-ophthalmic conditions are disorders that affect the complex connection between the eyes and the brain, involving the optic nerves, visual pathways and the intricate networks that control eye movements and pupil responses. When these systems are disrupted by neurological diseases, autoimmune conditions, infections or injuries, patients may experience symptoms such as vision loss, double vision, visual field defects, involuntary eye movements (nystagmus), unequal pupils (anisocoria) or headaches related to elevated intracranial pressure.

The causes are diverse and can include inflammatory or demyelinating diseases such as multiple sclerosis, vascular disorders such as stroke or giant cell arteritis and tumors involving or compressing the visual pathways. Additional causes include hereditary or genetic optic neuropathies, autoimmune or neuromuscular disorders such as myasthenia gravis and sarcoidosis, genetic syndromes such as neurofibromatosis, infections and complications of systemic diseases.

Because neuro-ophthalmic disorders often involve neurology, ophthalmology and other specialties, accurate diagnosis and effective management typically require a multidisciplinary approach. Early detection through comprehensive evaluation and advanced diagnostic testing is essential, as timely intervention can help preserve vision, prevent complications and improve long-term outcomes.

With locations in New York City and Westchester County, we serve all your neuro-ophthalmic care needs close to home and work.